drugset / Trial / NCT03312582

Locally Delivered 1% Metformin Gel in Peri-implantitis

NCT03312582 ↗

Phase 4 Completed 46 enrolled King Saud University
RandomizedParallel-groupTriple-blindTreatment

Summary

This study evaluates the efficacy of 1% local metformin gel in deep periimplant pockets of type 2 diabetes mellitus patients. Half of the participants will receive 1% metformin gel with manual debridement while the other half will receive a placebo with manual debridement.

Timeline

Start
2015-03-15
Primary completion
2016-08-14
Completion
2017-07-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 1 % Other

Indications